| 产品名称: | Streptococcus pyogenes Rosenbach |
|---|---|
| 商品货号: | TS144193 |
| Deposited As: | Streptococcus hemolyticus Rolly |
| Strain Designations: | S-43 |
| Application: | Produces antineoplastic agents Produces streptolysin O Produces streptolysin S Emerging infectious disease research |
| Isolation: | Human isolate |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties: | Lancefields group A |
| Product Format: | freeze-dried |
| Disclosure: | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®: | no |
| Type Strain: | no |
| Medium: | ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood |
| Growth Conditions: | Temperature: 37.0°C |
| Name of Depositor: | Chugai Seiyaku Kabushi Kaisha |
| U.S. Patent Number: | |
| Chain of Custody: | ATCC < |
| References: | Ogawa H, et al. Method of production of anti-tumor substances. US Patent 3,786,141 dated Jan 15 1974 |